Bio-Rad Laboratories (NYSE:BIO.B) Shares Cross Below 200-Day Moving Average – Here’s Why

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $324.63 and traded as low as $265.82. Bio-Rad Laboratories shares last traded at $265.82, with a volume of 11 shares traded.

Bio-Rad Laboratories Price Performance

The stock has a market capitalization of $7.45 billion, a P/E ratio of -4.09 and a beta of 0.75. The business has a fifty day simple moving average of $306.59 and a 200 day simple moving average of $324.21. The company has a current ratio of 6.48, a quick ratio of 4.85 and a debt-to-equity ratio of 0.18.

Bio-Rad Laboratories (NYSE:BIO.B) last issued its quarterly earnings data on Thursday, February 13th. The company reported $2.90 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a negative net margin of 71.86% and a positive return on equity of 3.90%.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.